Patients with low OCT-1 activity and high ABCB1 fold rise have poor long-term outcomes in response to tyrosine kinase inhibitor therapy

Research output: Contribution to journalArticle

4 Citations (Scopus)
LanguageEnglish
Pages2288-2291
Number of pages4
JournalLeukemia
Volume32
Issue number10
DOIs
Publication statusPublished - 1 Oct 2018

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this